Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction - PubMed (original) (raw)

doi: 10.1038/ni879. Epub 2003 Jan 13.

Affiliations

• PMID: 12524535
• DOI: 10.1038/ni879

Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction

Masako Murai et al. Nat Immunol. 2003 Feb.

Erratum in

• Nat Immunol. 2003 May;4(5):497

Abstract

Acute graft-versus-host disease (a-GVHD) is initiated primarily by immunologically competent cytotoxic T cells (CTLs) that express anti-host specificities. However, the host lymphoid compartment in which these precursor CTLs are initially stimulated remains unclear. Here we show that gut Peyer's patches (PPs) are required to activate anti-host CTL responses in a well characterized murine acute graft-versus-host reaction (a-GVHR) model, involving transfer of parent lymphocytes into F1 hybrid recipients. The a-GVHR was prevented when recruitment of donor T cells into PP was interrupted either by disrupting the gene encoding chemokine receptor CCR5 or by blocking integrin alpha(4)beta(7)-MAdCAM-1 (mucosal vascular addressin) interactions. Mice deficient for PPs failed to develop a-GVHD in two models of disease induction. Thus, blockade of CTL generation in PPs might offer new strategies for circumventing a-GVHD.

PubMed Disclaimer

Comment in

• Location, location, location.
  Ferrara J. Ferrara J. Nat Immunol. 2003 Feb;4(2):103-4. doi: 10.1038/ni0203-103. Nat Immunol. 2003. PMID: 12555092 No abstract available.

Similar articles

• Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
  Ueha S, Murai M, Yoneyama H, Kitabatake M, Imai T, Shimaoka T, Yonehara S, Ishikawa S, Matsushima K. Ueha S, et al. J Leukoc Biol. 2007 Jan;81(1):176-85. doi: 10.1189/jlb.0306231. Epub 2006 Oct 19. J Leukoc Biol. 2007. PMID: 17053165
• Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
  Yamamoto S, Tsuji T, Matsuzaki J, Zhange Y, Chamoto K, Kosaka A, Togashi Y, Sekikawa K, Sawada K, Takeshima T, Koike T, Nishimura T. Yamamoto S, et al. Int Immunol. 2004 Jun;16(6):811-7. doi: 10.1093/intimm/dxh082. Epub 2004 May 4. Int Immunol. 2004. PMID: 15126416
• Protection from lethal graft-vs.-host disease by donor stem cell repopulation.
  Rozendaal L, Pals ST, Melief CJ, Gleichmann E. Rozendaal L, et al. Eur J Immunol. 1992 Feb;22(2):575-9. doi: 10.1002/eji.1830220241. Eur J Immunol. 1992. PMID: 1347016
• Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies.
  Zeiser R, Marks R, Bertz H, Finke J. Zeiser R, et al. Ann Hematol. 2004 Sep;83(9):551-65. doi: 10.1007/s00277-004-0890-7. Epub 2004 Jun 15. Ann Hematol. 2004. PMID: 15449032 Review.
• Cytotoxic T lymphocytes: all roads lead to death.
  Barry M, Bleackley RC. Barry M, et al. Nat Rev Immunol. 2002 Jun;2(6):401-9. doi: 10.1038/nri819. Nat Rev Immunol. 2002. PMID: 12093006 Review.

Cited by

• Population pharmacokinetic modeling of vedolizumab for graft-versus-host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant.
  Waterhouse T, Baron K, Eure W, Chen C, Dirks NL, Jansson J, Akbari M, Mehrotra S. Waterhouse T, et al. Pharmacol Res Perspect. 2024 Oct;12(5):e1257. doi: 10.1002/prp2.1257. Pharmacol Res Perspect. 2024. PMID: 39233318 Free PMC article. Clinical Trial.
• Blockade of CCR5 and CXCR3 attenuates murine acute graft-versus-host disease through modulating donor-derived T-cell distribution and function.
  Tang B, Qin C, Liu H, Miao S, Xue C, Wang Z, Zhang Y, Dong Y, Liu W, Ren H. Tang B, et al. Int Immunol. 2024 Sep 10;36(10):541-552. doi: 10.1093/intimm/dxae033. Int Immunol. 2024. PMID: 38778574 Free PMC article.
• Separation of GVL from GVHD -location, location, location.
  Teshima T, Hashimoto D. Teshima T, et al. Front Immunol. 2023 Dec 5;14:1296663. doi: 10.3389/fimmu.2023.1296663. eCollection 2023. Front Immunol. 2023. PMID: 38116007 Free PMC article. Review.
• Centrosome clustering control in osteoclasts through CCR5-mediated signaling.
  Lee JW, Lee IH, Watanabe H, Liu Y, Sawada K, Maekawa M, Uehara S, Kobayashi Y, Imai Y, Kong SW, Iimura T. Lee JW, et al. Sci Rep. 2023 Nov 27;13(1):20813. doi: 10.1038/s41598-023-48140-2. Sci Rep. 2023. PMID: 38012303 Free PMC article.
• Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity.
  Larson JH, Jin S, Loschi M, Bolivar Wagers S, Thangavelu G, Zaiken MC, McDonald-Hyman C, Saha A, Aguilar EG, Koehn B, Osborn MJ, Panoskaltsis-Mortari A, Macdonald KPA, Hill GR, Murphy WJ, Serody JS, Maillard I, Kean LS, Kim SV, Littman DR, Blazar BR. Larson JH, et al. Am J Transplant. 2023 Aug;23(8):1102-1115. doi: 10.1016/j.ajt.2023.01.030. Epub 2023 Mar 4. Am J Transplant. 2023. PMID: 36878433 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal